Ana Maria García Collazo

Title: Ana Maria García Collazo: Innovator in Pharmaceutical Chemistry

Introduction

Ana Maria García Collazo is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of lysosomal storage diseases and synucleinopathies. With a total of six patents to her name, her work is recognized for its potential impact on medical science.

Latest Patents

Among her latest patents is a groundbreaking application focused on heteroaryl compounds and their use. This patent is directed to compounds of a specific formula and their salts and solvates, which are crucial for treating and preventing lysosomal storage diseases, such as Gaucher's disease. Another notable patent involves a process for preparing a specific thiazolidinedione compound and its pharmaceutically acceptable salts. This process outlines the method for synthesizing the compound and its intermediates, showcasing her expertise in pharmaceutical formulations.

Career Highlights

Ana Maria García Collazo is currently associated with Minoryx Therapeutics S.L., where she continues to advance her research and development efforts. Her work at this company emphasizes her commitment to innovation in the pharmaceutical industry.

Collaborations

She collaborates with esteemed colleagues, including Xavier Barril Alonso and Elena Cubero Jordà, who contribute to her research endeavors and enhance the collaborative spirit within her team.

Conclusion

Ana Maria García Collazo stands out as a leading inventor in pharmaceutical chemistry, with her innovative patents paving the way for advancements in the treatment of complex diseases. Her contributions are vital to the ongoing evolution of medical therapies.